Legal & General Group Portfolio holdings
Legal & General Group Plc, founded in 1836 by six lawyers in London, is a British multinational financial services company headquartered in London, renowned for its leadership in insurance, pensions, and investment management. Managing trillions in assets, the firm operates through key divisions like Legal & General Investment Management (LGIM), one of the UK’s largest asset managers, focusing on index funds, active strategies, and sustainable investing for institutional clients like pension funds. It also provides life insurance, retirement products, and general insurance, serving millions of customers with a strong emphasis on long-term financial security and infrastructure investment, such as affordable housing. With a heritage of stability and a modern push toward ESG (environmental, social, governance) principles, Legal & General remains a cornerstone of the UK financial landscape with a growing global presence.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$594M |
| 2 |
Microsoft
MSFT
|
+$460M |
| 3 |
Broadcom
AVGO
|
+$406M |
| 4 |
Cisco
CSCO
|
+$241M |
| 5 |
Meta Platforms (Facebook)
META
|
+$217M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ATVI
Activision Blizzard
ATVI
|
+$450M |
| 2 |
VMW
VMware, Inc
VMW
|
+$293M |
| 3 |
SGEN
Seagen Inc. Common Stock
SGEN
|
+$189M |
| 4 |
SPLK
Splunk Inc
SPLK
|
+$165M |
| 5 |
Danaher
DHR
|
+$124M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29.62% |
| 2 | Healthcare | 12.35% |
| 3 | Financials | 12.25% |
| 4 | Consumer Discretionary | 9.98% |
| 5 | Industrials | 7.89% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PKST
2301
DELISTED
Peakstone Realty Trust
PKST
| $757K | ﹤0.01% |
37,994
| – | – |
|
|
RDUS
2302
DELISTED
Radius Recycling
RDUS
| $756K | ﹤0.01% |
25,077
-1,535
| -6% | -$40.4K |
|
2303
Pliant Therapeutics
PLRX
$65.6M
| $756K | ﹤0.01% |
41,734
-184
| -0.4% | -$2.8K |
|
|
IAS
2304
DELISTED
Integral Ad Science
IAS
| $755K | ﹤0.01% |
52,478
+4,121
| +9% | +$55.1K |
|
2305
Driven Brands
DRVN
$2.06B
| $753K | ﹤0.01% |
52,833
-282
| -0.5% | -$3.52K |
|
2306
Viridian Therapeutics
VRDN
$2.62B
| $753K | ﹤0.01% |
34,566
+7,206
| +26% | +$114K |
|
2307
Keros Therapeutics
KROS
$210M
| $751K | ﹤0.01% |
18,876
-50
| -0.3% | -$1.57K |
|
2308
QCR Holdings
QCRH
$1.7B
| $746K | ﹤0.01% |
12,775
+342
| +3% | +$17.7K |
|
2309
Maravai LifeSciences
MRVI
$900M
| $741K | ﹤0.01% |
113,063
| – | – |
|
2310
Univest Financial
UVSP
$1.17B
| $740K | ﹤0.01% |
33,581
| – | – |
|
2311
Garrett Motion
GTX
$5.52B
| $740K | ﹤0.01% |
76,501
| – | – |
|
2312
Vita Coco
COCO
$3.59B
| $738K | ﹤0.01% |
28,770
-792
| -3% | -$21.5K |
|
2313
CryoPort
CYRX
$765M
| $737K | ﹤0.01% |
47,590
+280
| +0.6% | +$3.66K |
|
2314
Ultrapar
UGP
$6.51B
| $735K | ﹤0.01% |
135,500
| – | – |
|
2315
Kimbell Royalty Partners
KRP
$1.5B
| $734K | ﹤0.01% |
48,785
| – | – |
|
|
RVNC
2316
DELISTED
Revance Therapeutics, Inc.
RVNC
| $734K | ﹤0.01% |
83,463
+163
| +0.2% | +$1.33K |
|
|
INBX
2317
DELISTED
Inhibrx, Inc. Common Stock
INBX
| $732K | ﹤0.01% |
19,265
-2,896
| -13% | -$62.1K |
|
2318
Amplitude
AMPL
$1.56B
| $729K | ﹤0.01% |
57,293
+2,739
| +5% | +$30.4K |
|
2319
Center Bancorp
CNOB
$1.78B
| $728K | ﹤0.01% |
31,788
+1,948
| +7% | +$37.5K |
|
2320
IMAX
IMAX
$2.84B
| $724K | ﹤0.01% |
48,197
+1,066
| +2% | +$18.2K |
|
|
LPRO
2321
DELISTED
Open Lending Corp
LPRO
| $724K | ﹤0.01% |
85,047
+2,601
| +3% | +$17.5K |
|
|
DCBO
2322
Docebo
DCBO
$592M
| $722K | ﹤0.01% |
14,881
-176
| -1% | -$7.84K |
|
|
VERV
2323
DELISTED
Verve Therapeutics
VERV
| $721K | ﹤0.01% |
51,730
+12,880
| +33% | +$160K |
|
2324
Life Time Group Holdings
LTH
$9.66B
| $717K | ﹤0.01% |
47,548
| – | – |
|
2325
Revolve Group
RVLV
$1.7B
| $717K | ﹤0.01% |
43,229
+1,659
| +4% | +$24.5K |
|
Similar funds
Legal & General Group's Q4 2023 Portfolio in Review
As of Q4 2023, Legal & General Group held 3,426 positions worth $322B, up 12% from $287B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Trading was light in Q4 2023: portfolio turnover was 1.8%. Legal & General Group opened 15 new positions and exited 47, leaving the 3,426-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 28% a quarter earlier, followed by Healthcare and Financials.
- Legal & General Group's largest Q4 2023 buy was WK Kellogg Co: 403,883 shares worth $5.31M.
- Legal & General Group added most to Apple in Q4 2023, an estimated $594M increase.
- Legal & General Group's biggest Q4 2023 reduction was Splunk Inc, cutting an estimated $165M.
- Legal & General Group fully exited Activision Blizzard in Q4 2023, selling an estimated $450M.
- Legal & General Group's ten largest holdings make up 26% of its $322B portfolio in Q4 2023.
- Legal & General Group opened 15 new positions and closed 47 in Q4 2023.
- Legal & General Group's portfolio value rose 12% quarter-over-quarter to $322B.
Based on Legal & General Group's 13F filing for Q4 2023, filed 15 Feb 2024.